Dermatitis News

Recently published studies have compared guidelines for atopic dermatitis management and the possible contribution of human skin mast cells to the skin disorder.

The American Academy of Dermatology announced that more than 18,500 people attended its annual meeting, held from March 20-24 in San Francisco.

Although the basic principles of atopic dermatitis management were similar in various guidelines, recommendations regarding adjunctive therapies differed, according to a recently published review.

Environmental chemical contaminants such as organochlorines and perfluorooctanoic acid were inversely associated with the development of childhood asthma and eczema, according to study results.

U.S. Marshals seized unapproved prescription drug products valued at more than $1.5 million from Stratus Pharmaceuticals in Miami, according to a press release from the FDA.

Human skin mast cells are previously unrecognized interleukin-22 producers and express interleukin-17 that may contribute to inflammatory skin disorders, according to study results.

AN2728 ointment 2%, a novel boron-based small-molecule ointment, might be effective for the treatment of patients ages 2 years and older with mild-to-moderate atopic dermatitis, according to research presented during a late-breaking research session.

Healio.com/Dermatology will provide coverage of the American Academy of Dermatology Annual Meeting in San Francisco beginning Friday.

An ICD-9-CM–based algorithm was validated by accurately identifying patients with chronic idiopathic urticaria and chronic spontaneous urticaria, according to study results.

DermSpectra has announced an original equipment manufacturer relationship with Nikon, in which a Nikon D810 camera and NIKKOR optics will be integrated into its Total Body Digital Skin-Imaging System.